Literature DB >> 20361788

Rates and equilibria for probe capture by an antibody with infinite affinity.

Tolulope A Aweda1, Heather E Beck, Anna M Wu, Liu H Wei, Wolfgang A Weber, Claude F Meares.   

Abstract

Probe-capture systems based on proteins and synthetic ligands have become important for new analytical and imaging applications. We have used kinetic measurements of luminescence and measurements of binding by isothermal calorimetry to determine essential rate and equilibrium constants for a system that permanently captures modified DOTA chelates for positron imaging. We used that information along with previous results to quantitatively characterize the behavior of this system in vitro and in vivo. Under physiological conditions at 37 degrees C, the equilibrium dissociation constant for yttrium S-2-(4-aminobenzyl)-1,4,7,10-tetraazacyclododecanetetraacetate from antibody 2D12.5 is 2.0 (+/- 0.4) x 10(-9) M and the dissociation rate constant is 7.0 (+/- 0.7) x 10(-3) s(-1), leading to an inferred association rate constant of 3.5 x 10(6) M(-1) s(-1). Using these values to interpret data from earlier experiments leads to the rate constant 2.5 x 10(-2) s(-1) for covalent attachment of bound yttrium S-2-(4-acrylamidobenzyl)-1,4,7,10-tetraazacyclododecanetetraacetate to the G54C mutant of antibody 2D12.5. These values lead to a model for the detailed behavior of the latter system for tumor imaging in vivo that is consistent with experimental observations.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20361788      PMCID: PMC2862285          DOI: 10.1021/bc100046p

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  25 in total

1.  Exact analysis of competition ligand binding by displacement isothermal titration calorimetry.

Authors:  B W Sigurskjold
Journal:  Anal Biochem       Date:  2000-01-15       Impact factor: 3.365

2.  Antibodies with infinite affinity.

Authors:  A J Chmura; M S Orton; C F Meares
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-10       Impact factor: 11.205

3.  Energetic roles of hydrogen bonds at the ureido oxygen binding pocket in the streptavidin-biotin complex.

Authors:  L A Klumb; V Chu; P S Stayton
Journal:  Biochemistry       Date:  1998-05-26       Impact factor: 3.162

4.  A rare earth-DOTA-binding antibody: probe properties and binding affinity across the lanthanide series.

Authors:  Todd M Corneillie; Paul A Whetstone; Andrew J Fisher; Claude F Meares
Journal:  J Am Chem Soc       Date:  2003-03-26       Impact factor: 15.419

5.  Crystal structures of two complexes of the rare-earth-DOTA-binding antibody 2D12.5: ligand generality from a chiral system.

Authors:  Todd M Corneillie; Andrew J Fisher; Claude F Meares
Journal:  J Am Chem Soc       Date:  2003-12-10       Impact factor: 15.419

6.  Comparison of anti-CD20 and anti-CD45 antibodies for conventional and pretargeted radioimmunotherapy of B-cell lymphomas.

Authors:  John M Pagel; Nathan Hedin; Krishnan Subbiah; Damon Meyer; Robert Mallet; Donald Axworthy; Louis J Theodore; D Scott Wilbur; Dana C Matthews; Oliver W Press
Journal:  Blood       Date:  2002-11-21       Impact factor: 22.113

7.  Conjugation of antibodies with bifunctional chelating agents: isothiocyanate and bromoacetamide reagents, methods of analysis, and subsequent addition of metal ions.

Authors:  C F Meares; M J McCall; D T Reardan; D A Goodwin; C I Diamanti; M McTigue
Journal:  Anal Biochem       Date:  1984-10       Impact factor: 3.365

8.  Tris-nitrilotriacetic acids of subnanomolar affinity toward hexahistidine tagged molecules.

Authors:  Zhaohua Huang; Peter Hwang; Douglas S Watson; Limin Cao; Francis C Szoka
Journal:  Bioconjug Chem       Date:  2009-08-03       Impact factor: 4.774

9.  Pharmacokinetics of pretargeted monoclonal antibody 2D12.5 and 88Y-Janus-2-(p-nitrobenzyl)-1,4,7,10-tetraazacyclododecanetetraacetic acid (DOTA) in BALB/c mice with KHJJ mouse adenocarcinoma: a model for 90Y radioimmunotherapy.

Authors:  D A Goodwin; C F Meares; N Watanabe; M McTigue; W Chaovapong; C M Ransone; O Renn; D P Greiner; D L Kukis; S I Kronenberger
Journal:  Cancer Res       Date:  1994-11-15       Impact factor: 12.701

10.  Modeling analysis of the global and microscopic distribution of immunoglobulin G, F(ab')2, and Fab in tumors.

Authors:  K Fujimori; D G Covell; J E Fletcher; J N Weinstein
Journal:  Cancer Res       Date:  1989-10-15       Impact factor: 12.701

View more
  5 in total

1.  New covalent capture probes for imaging and therapy, based on a combination of binding affinity and disulfide bond formation.

Authors:  Tolulope A Aweda; Vahid Eskandari; David L Kukis; David L Boucher; Bernadette V Marquez; Heather E Beck; Gregory S Mitchell; Simon R Cherry; Claude F Meares
Journal:  Bioconjug Chem       Date:  2011-07-22       Impact factor: 4.774

2.  Covalent stabilization of a small molecule-RNA complex.

Authors:  Hayden Peacock; Radhika Bachu; Peter A Beal
Journal:  Bioorg Med Chem Lett       Date:  2011-05-05       Impact factor: 2.823

3.  Antibody with Infinite Affinity for In Vivo Tracking of Genetically Engineered Lymphocytes.

Authors:  Simone Krebs; Afruja Ahad; Lukas M Carter; Justin Eyquem; Christian Brand; Meghan Bell; Vladimir Ponomarev; Thomas Reiner; Claude F Meares; Stephen Gottschalk; Michel Sadelain; Steven M Larson; Wolfgang A Weber
Journal:  J Nucl Med       Date:  2018-06-14       Impact factor: 10.057

4.  Combination of isothermal titration calorimetry and time-resolved luminescence for high affinity antibody-ligand interaction thermodynamics and kinetics.

Authors:  Tolulope A Aweda; Claude F Meares
Journal:  Methods       Date:  2011-09-20       Impact factor: 3.608

Review 5.  Chemically modified antibodies as diagnostic imaging agents.

Authors:  Jeffrey J Day; Bernadette V Marquez; Heather E Beck; Tolulope A Aweda; Prasad D Gawande; Claude F Meares
Journal:  Curr Opin Chem Biol       Date:  2010-10-15       Impact factor: 8.822

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.